Factors associated with outcomes of second-line treatment for EGFR-mutant non-small-cell lung cancer patients after progression on first- or second-generation EGFR-tyrosine kinase inhibitor treatment
Article in Frontiers in Oncology (June 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (June 2023)
Article in Targeted Oncology (February 2023)
Article in Oncology Letters (September 2022)